Bayer AG
Viés de alta

Late cycle. Medicine ++

336
In November 2023, it was reported that German chemical concern Bayer AG was considering options for splitting the business due to weak financial performance.

Management considered several options:

spinning off the health products or agricultural fertilizer businesses into a separate company;
maintaining a three-division structure but getting rid of non-core assets;
successive splits into three independent companies, each retaining its own divisions.

In January 2024, it was reported that Bayer announced a business restructuring and job cuts. The plan was to simplify the management model, eliminate bureaucracy and speed up decision-making processes. The job cuts were expected to begin in the coming months and should be completed by the end of 2025.

This company could go the same way as deutsche bank.

Get up off your knees and grow a few times over. =)

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.